Nippon Chemiphar announces positive results from phase-1 trial of NC-2500, a novel XOR inhibitor
Nippon Chemiphar has announced that the phase-1 clinical trial of NC-2500, a novel xanthine oxidoreductase (XOR) inhibitor, was completed, indicating...
Kyowa Hakko Kirin Submits the Partial Change Approval Application of Mogamulizumab in Japan
Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and CEO: Nobuo Hanai; announces the submission of a supplemental application to...
Navitas Brings End-to-End R&D Solutions to the Generic Drug Industry
Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver "first to file" results to generic drug...
Sankyo to Convert Kitasato Daiichi Sankyo Vaccine into Wholly Owned Subsidiary
Daiichi Sankyo Company, Limited announced that its Board of Directors approved a resolution to convert Daiichi Sankyo’s consolidated subsidiary, Kitasato...
Allergan’s Migraine Leadership Recognized with Enrico Greppi Award for Excellence in Headache Research
Allergan plc , a leading global pharmaceutical company, is pleased to announce that its manuscript, "Fluctuations in Episodic and Chronic...
Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002
Capricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to...
Daiichi Sankyo Launches Anticoagulant LixianaⓇ OD Tablets (orally disintegrating tablets) in Japan
Daiichi Sankyo Company, Limited announced that it has launched its oral anticoagulant LixianaⓇ OD Tablets 15 mg, 30 mg and...
Aimovig Phase 3 STRIVE Data Published In The New England Journal Of Medicine Demonstrate Significant, Sustained Efficacy In Migraine Prevention
Amgen announced that the New England Journal of Medicine (NEJM) published positive results from the six-month Phase 3 STRIVE study...
Merck Receives FDA Approval for ISENTRESS , in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection
Merck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir),...
Surge in RNAscope and BaseScope Assay publications now includes pharma, biotech and new research areas – and use as a core assay
Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is celebrating a milestone in the adoption of its RNAscope® in situ hybridization...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.